Blood Glucose Testing - Global Market Research Report, Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The blood glucose testing market is expected to grow from USD 12,703.56 Million in 2018 to USD 23,529.78 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.20%. The growth in the market is majorly attributed to key benefits of cgms over poc glucometers, need an effective way to detect drastic changes in blood glucose for increasing diabetes cases, and technological advancements and increased awareness.
Market Segmentation & Coverage:
On the basis of Product, the Blood Glucose Testing Market is studied across Glucose Meter, Test Strips, and Lancets.
On the basis of Distribution Channel, the Blood Glucose Testing Market is studied across Offline and Online.
On the basis of End-User, the Blood Glucose Testing Market is studied across Pathology and Self-users.
On the basis of Geography, the Blood Glucose Testing Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
FPNV Positioning Matrix:
360iResearch has come out with an interactive and evolving FPNV Positioning Matrix for blood glucose testing market. The FPNV Positioning Matrix evaluates and categorizes the vendors in the blood glucose testing market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the blood glucose testing market including are AgaMatrix Inc., ARKRAY, Inc., Bayer AG, Becton, Dickinson and Company, Dynarex Corporation, LifeScan, Inc., Abbott Laboratories, Cambridge Sensors Limited, Dexcom, Inc., Integrity Applications Incorporated, Johnson & Johnson Services, Inc., Medtronic plc, Novo Nordisk A/S, ORSENSE LTD, Owen Mumford Ltd., Roche Holding AG, Senseonics Holdings, Inc., US MED, LLC., and Veridian Healthcare.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the blood glucose testing market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the blood glucose testing market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the blood glucose testing market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the blood glucose testing market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the blood glucose testing market
The report answers questions such as:
1. What is the market size of blood glucose testing market in the global?
2. What are the factors that affect the growth in the blood glucose testing market over the forecast period?
3. What is the competitive position in the blood glucose testing market?
4. Which are the best product areas to be invested in over the forecast period in the blood glucose testing market?
5. What are the opportunities in the blood glucose testing market?
6. What are the modes of entering the blood glucose testing market?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook